Fetal health assessment in utero by laboratory technologies: clinical benefits, risks and controversies.
Department of Pathology, Stanford University School of Medicine, Palo Alto, CA, USA. Electronic address: sgeaghan@stanford.edu.
Sharon M
SM
Geaghan
D001805:Blood Transfusion, Intrauterine / Q000379:methods; D017218:Cordocentesis / Q000379:methods*; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis* / Q000378:metabolism; D005332:Fetoscopy / Q000379:methods*; D005333:Fetus / Q000002:abnormalities / Q000737:chemistry* / Q000378:metabolism / Q000601:surgery; D006801:Humans; D053685:Laser Therapy / Q000379:methods; D008028:Light Coagulation / Q000379:methods; D011247:Pregnancy; D011296:Prenatal Diagnosis / Q000295:instrumentation / Q000379:methods*; D012015:Reference Standards; D012016:Reference Values; D018570:Risk Assessment